Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001610717-23-000403)

Filing Details

Accession Number:: 0001610717-23-000403
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-18 17:45:13
Reporting Period:: 2023-12-14

Accepted Time:: 2023-12-18 17:45:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1676725	Ideaya Biosciences Inc.	IDYA	Pharmaceutical Preparations (2834)	474268251

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1983118	Andres Briseno Ruiz	C/O Ideaya Biosciences, Inc. 7000 Shoreline Court, Suite 350 South San Francisco CA 94080	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-14	1,672	$34.00	30,859	No	4	S	Direct
Common Stock	Disposition	2023-12-14	328	$34.01	30,531	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023.